47 related articles for article (PubMed ID: 9211755)
1. Parathyroid adenoma detected with 99mTc-tetrofosmin dual-phase scintigraphy: a case report.
Romanidis K; Karathanos E; Nagorni EA; Giatromanolaki A; Sibridis E; Zissimopoulos A; Vogiatzaki T; Simopoulos C; Pitiakoudis M
BMC Res Notes; 2014 Jun; 7():335. PubMed ID: 24894734
[TBL] [Abstract][Full Text] [Related]
2. The role of nuclear medicine in differentiated thyroid cancer.
Kohlfürst S
Wien Med Wochenschr; 2012 Oct; 162(19-20):407-15. PubMed ID: 22815124
[TBL] [Abstract][Full Text] [Related]
3. Current role of radionuclide imaging in differentiated thyroid cancer.
Wong KT; Choi FP; Lee YY; Ahuja AT
Cancer Imaging; 2008 Sep; 8(1):159-62. PubMed ID: 18818134
[TBL] [Abstract][Full Text] [Related]
4. [The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
Hod N; Strauss S; Horne T
Harefuah; 2001 May; 140(5):421-4. PubMed ID: 11419067
[No Abstract] [Full Text] [Related]
5. The role of F-18FDG PET in thyroid cancer.
Lind P; Kumnig G; Matschnig S; Heinisch M; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Unterweger O
Acta Med Austriaca; 2000; 27(2):38-41. PubMed ID: 10812462
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.
Kresnik E; Gallowitsch HJ; Mikosch P; Molnar M; Pipam W; Gomez I; Lind P
Eur J Nucl Med; 1997 Jul; 24(7):716-21. PubMed ID: 9211755
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M
Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of Tc-99m tetrofosmin scintigraphy in patients with cold thyroid nodules. Comparison with color Doppler sonography.
Erdem S; Baŝhekim C; Kizilkaya E; Ince M; Karsli F
Clin Nucl Med; 1997 Feb; 22(2):76-9. PubMed ID: 9031763
[TBL] [Abstract][Full Text] [Related]
9. The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter.
Karayalçin U; Ciftçi F; Boz A; Boz S; Karayalçin B
Ann Nucl Med; 1997 Nov; 11(4):285-90. PubMed ID: 9460519
[TBL] [Abstract][Full Text] [Related]
10. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
[TBL] [Abstract][Full Text] [Related]
11. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
13. Preoperative scintigraphic and intraoperative scintimetric localization of parathyroid adenoma with cationic Tc-99m complexes and a hand-held gamma-probe.
Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Lind P
Nuklearmedizin; 1997 Jan; 36(1):13-8. PubMed ID: 9037679
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area.
Kresnik E; Gallowitsch HJ; Mikosch P; Gomez I; Lind P
J Nucl Med; 1997 Jan; 38(1):62-5. PubMed ID: 8998152
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
